WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-04-03
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 35
- Registration Number
- NCT00455325
- Locations
- πΊπΈ
Washington University in St. Louis, Saint Louis, Missouri, United States
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-03
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 357
- Registration Number
- NCT00455403
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-03-02
- Last Posted Date
- 2015-07-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 6
- Registration Number
- NCT00442507
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-02-01
- Last Posted Date
- 2014-08-29
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 21
- Registration Number
- NCT00429949
- Locations
- πΊπΈ
Washington Universtiy in St. Louis, St. Louis, Missouri, United States
Renal Transplantation With Immune Monitoring
Completed
- Conditions
- First Posted Date
- 2007-01-08
- Last Posted Date
- 2008-06-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT00419575
- Locations
- πΊπΈ
Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Validation of a Molecular Prognostic Test for Eye Melanoma
Withdrawn
- Conditions
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT00406120
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Research for Elimination of Lymphatic Filariasis (ICIDR)
Completed
- Conditions
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2008-09-09
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 117500
- Registration Number
- NCT00406627
- Locations
- πͺπ¬
Ain Shams University, Cairo, Egypt
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2016-12-12
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT00384956
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
- First Posted Date
- 2006-10-03
- Last Posted Date
- 2016-01-11
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 9
- Registration Number
- NCT00383266
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
Treatment of Acute Sinusitis
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2012-12-28
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 172
- Registration Number
- NCT00377403
- Locations
- πΊπΈ
Washington University in St. Louis, St. Louis, Missouri, United States
Β© Copyright 2024. All Rights Reserved by MedPath